
Should You Get a Blood Test For Alzheimer's?
Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much–yet.
Josh Fischman is a senior editor at Scientific American who covers medicine, biology and science policy. He has written and edited about science and health for Discover, Science, Earth, and U.S. News & World Report. Follow Josh Fischman on Twitter.
Consumers can now get easy tests for Alzheimer’s. But these tests may not really help patients that much–yet.
The bite of the lone star tick makes people allergic to a sugar found in mammalian products, and many doctors don’t know about it.
Hearing aids may help maintain better brain functions in older people and better health overall.
In inflammatory bowel disease, mental stress can produce two painful responses
Drugs such as Wegovy and Ozempic might help people tackle substance abuse as well as shed pounds.
Inflammatory bowel disease flare-ups can be traced to mental stress
ChatGPT and other AI programs can offer medical advice. But how good are they?
Your body has a secret cooling method, and scientists explain how to use it.
The party drug MDMA could soon be approved for treating people with severe PTSD.
What you pay for tests, vaccines, and medicine will change
We learn the story of “Ella,” a patient with 12 different personalities, or “parts,” and of her therapist, who helped her form a peaceful community—many selves in one body and mind...
Recent rulings on the abortion pill cite the Comstock Act, a 150-year-old law that’s still on the books
Very high HDL cholesterol levels almost double your risk of heart problems.
A careful new study reveals coffee is generally safe for your heart and may boost your daily step count.
Post-COVID symptoms can linger for months or years, and more and more evidence points to problems with the nervous system.
A vaccine pioneer tells us that shots to protect against RSV—a dangerous virus for babies and older people—are finally nearing approval.
Hosts Josh Fischman and Tanya Lewis explore the pandemic’s mental health toll on teens and young adults. They also delve into the effectiveness of telehealth, which has been booming since the start of the pandemic...
Vaccines saved New York City billions of dollars, and China faces public fury over its strict virus-control policies.
In a new episode of the COVID, Quickly podcast, we talk about the variants that are likely to be around this winter and how boosters help even if you’ve already had the disease...
In this episode of the COVID, Quickly podcast, we talk about why we’ve had years shaved off our average collective life since 2020. Also, we talk about “mabs” and why you might want to know what they are...
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account